Filter
136
Filtered Results: 136
Text search:
L.
Anderson,
PharmD
Featured
Recommendations
13
New Publications
16
Language
Document type
No document type
54
Studies & Reports
37
Guidelines
25
Manuals
8
Training Material
4
Strategic & Response Plan
4
Fact sheets
3
Resource Platforms
1
Countries / Regions
Kenya
4
Latin America and the Carribbean
3
Brazil
3
Russia
3
India
3
Thailand
2
Ukraine
2
Ghana
2
Global
2
Africa
2
Cambodia
2
Germany
2
Jamaica
2
Argentina
2
Bangladesh
2
South Africa
2
Nepal
1
Lesotho
1
Sierra Leone
1
China
1
Philippines
1
Guinea
1
Mozambique
1
Guinea-Bissau
1
Tanzania
1
Western and Central Europe
1
United Kingdom
1
Spain
1
Vietnam
1
Eastern Europe
1
Angola
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
33
Clinical Guidelines
12
Public Health
10
Women & Child Health
4
Capacity Building
3
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
25
Mental Health
18
HIV
13
NCDs
12
AMR
11
TB
7
Caregiver
7
Pharmacy
7
Global Health Education
6
Rapid Response
4
Planetary Health
4
NTDs
2
Ebola
1
Social Ethics
1
Polio
1
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
16-17 march 2015, Geneva, Switzerland
Meeting report
Lancet Psychiatry 2016;3: 415–24
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud...
24 marzo 2020
El objetivo de este documento es elaborar una lista de medicamentos esenciales para manejar los pacientes en unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID -19. Incluye principios activos con su forma farmacéutica y concentración —preferentemente e...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
Orientations provisoires 19 juillet 2021
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
The revised package of BFHI materials includes five sections: 1. Background and Implementation, 2. Strengthening and Sustaining the BFHI: A course for decision-makers, 3. Breastfeeding Promotion and Support in a Baby-friendly Hospital: a 20-hour course for maternity staff, 4. Hospital Self-Appraisal...
